Anbio Biotechnology (NNNN) Liabilities and Shareholders Equity (2023 - 2025)
Anbio Biotechnology's quarterly Liabilities and Shareholders Equity came in at $30.2 million in Q4 2025, up 59.83% year-on-year from $18.9 million in Q4 2024, and up 59.83% quarter-over-quarter from $18.9 million in Q4 2024.
Anbio Biotechnology has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $30.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 8.78 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 4.11 Bn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 14.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 12.42 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 6.31 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 19.85 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 5.10 Bn |
| 10 | Anbio Biotechnology | 1.32 Bn | 1.31 Bn | - | 30.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.24 Mn |
| Jun 30, 2025 | 27,680.59 Bn |
| Dec 31, 2024 | 18.92 Mn |
| Dec 31, 2023 | 15.81 Mn |